Pfizer get USFDA nod for XELJANZ (tofacitinib) to treat active polyarticular course juvenile idiopathic arthritis
Two formulations were approved, a tablet and an oral solution, and are dosed based upon weight
-
According to a new study published in Scientometrics, scientific articles that get downloaded from the scholarly piracy website Sci-Hub tend...
-
Ironically, Charles Barry was born just a stone’s throw from his greatest work. Born in Bridge Street, Westminster, his masterpiece is co...
-
AICTE, CGPDTM sign MoU to spread ‘Intellectual Property Literacy’ New Delhi, Jan 18: The All India Council for Technical Education (AIC...
